Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

EWY vs IBB: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, EWY returned +79.7% to IBB's +37.5%, and IBB charges 0.44% to EWY's 0.59%.

askIQ about this page

askIQ about EWY and IBB

Net assets: $24.4bn on Oct 28, 2026 for iShares MSCI South Korea ETF, and $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF.

At a glance
+79.7%
EWY total return, 1 year
+37.5%
IBB total return, 1 year
0.59%
EWY expense ratio
0.44%
IBB expense ratio

Pair scorecard

IBB costs 0.15 points a year less; their one-year returns differ by 42.2 points; EWY is 2.1 times larger.

EWY vs IBB: Differences, Returns & Fees
MeasureEWYIBB
Return
Total return, 1 year+79.7%+37.5%
Drawdown
Below its high24.3%, high on Jun 18, 2026
Benchmark
What it tracksMSCI Korea 25/50 Daily 25 Capped IndexBiotech
Cost and size
Expense ratio0.59%0.44%
Net assets, as of Oct 26, 2026$22.5bn$10.7bn
Active share vs the S&P 50099%
Holdings
Holdings in common0%
Top ten holdings, share of the fund60.9%50%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, EWY and IBB hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first EWY IBB
Only in one fund ↓
Only in EWY
SAMSUNG ELECTRONICS LTD 23.14%
SK HYNIX 23.11%
SK SQUARE 2.78%
SAMSUNG ELECTRO MECHANICS LTD 2.67%
KB FINANCIAL GROUP 2.06%
SHINHAN FINANCIAL GROUP 1.54%
HYUNDAI MOTOR 1.51%
HANA FINANCIAL GROUP 1.39%
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
VERTEX PHARMACEUTICALS 7.53%
REGENERON PHARMACEUTICALS 5.64%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
Check overlap with more funds →

Side by side

EWY iShares MSCI South Korea ETF IBB iShares Biotechnology ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks the MSCI South Korea Biotech
Total return, 1 year +79.7% +37.5%
Its benchmark over the same days +16.3% (EEM) not measured
Gap to its benchmark +63.4 pts vs EEM not measured
Expense ratio 0.59% 0.44%
Already in the S&P 500 0.0% 40.2%
Holdings 78 245
Net assets, EWY as of Oct 28, 2026 and IBB as of Oct 27, 2026 $24.4bn $11.0bn

EWY and IBB on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

EWY and IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
EWY

EWY tracks the MSCI South Korea. Over the year to Oct 28, 2026 it returned +79.7% with distributions reinvested, against +16.3% for its benchmark, the MSCI Emerging Markets Index. The prospectus expense ratio is 0.59% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 78 positions, with the top ten at 60.9%. It sat 24.3% below its high of Jun 18, 2026 on Oct 28, 2026.

IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

Questions people ask

Are EWY and IBB in the same category?
EWY is a stock ETF and IBB is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, EWY or IBB?
In the year to Oct 28, 2026, with distributions reinvested, EWY returned +79.7% and IBB +37.5%.
Which is cheaper, EWY or IBB?
IBB is cheaper, by 0.15 percentage points a year. That is about $15 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do EWY and IBB overlap with the S&P 500?
By their latest filed holdings, 0% of EWY and 40% of IBB by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, EWY against IBB, data as of Oct 28, 2026. https://etfiq.com/compare/any/ewy-vs-ibb

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.